Aerami Therapeutics
Aerami is developing therapies to address the unmet medical needs of people with serious and rare forms of pulmonary hypertension, including pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension.
Company Location
600 Park Offices Drive, Suite 300
Durham
NC
27709
County
Region
Company Details
Company type
Year founded
2010
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Potential end market(s)
Products under development
AER-901 (Inhaled Imatinib)